Skip to main content

Table 1 Characteristics of patients enrolled in the study

From: The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda

Characteristic

 

Enrolled in survey N = 1537 n (%)

Included for molecular analysis N = 973 n (%)

Not included for molecular analysis N = 564 n (%)

p-value

Sex

Male

1018 (66.2)

630 (64.7)

388 (68.8)

0.106

 

Female

519 (33.8)

343 (35.3)

176 (31.2)

 

Age

13-14

33 (2.2)

21 (2.2)

12 (2.1)

0.956

 

15-24

299 (19.5)

189 (19.8)

108(19.2)

 
 

25-34

521 (33.4)

330 (34.3)

191 (34.0)

 
 

35-44

366 (23.8)

235 (24.5)

131 (23.3)

 
 

45-54

167 (10.9)

100 (10.4)

67 (11.9)

 
 

>55

139 (9.0)

86 (9.0)

53 (9.43)

 

HIV already diagnosed positive

Yes

339 (22.1)

217 (22.3)

122 (21.6)

0.586

 

No

873 (53.6)

527 (54.2)

296 (52.5)

 
 

Unknown

375 (24.4)

229 (23.5)

146 (25.9)

 

TB control Zone

South West

482 (31.4)

278 (28.6)

204 (36.2)

0.004

Kampala

457 (29.7)

313 (31.2)

144 (25.5)

 

South East

97 (6.3)

59 (6.1)

38 (6.7)

 

Eastern

53 (3.5)

28 (2.9)

25 (4.4)

 

North East

152 (9.9)

89 (9.2)

63 (11.2)

 

North

52 (3.4)

36 (3.7)

16 (2.8)

 

North West

149 (9.7)

104 (10.7)

45 (8.0)

 

Western

95 (6.2)

66 (6.8)

29 (5.1)

 

HIV results at (re)testing

Positive

469 (30.5)

297 (30.5)

172 (30.5)

0.216

Negative

1054 (68.6)

664 (68.2)

390 (69.2)

 

Missing

14 (0.91)

12 (1.23)

2 (0.35)

 

Previous TB treatment

Yes

140 (9.2)

78 (8.1)

62 (11.3)

0.057

 

No

1397 (90.8)

883 (91.9)

500 (89.0)